SQUIBB's WORLDWIDE CORGARD SALES CLIMB 26% TO $105 MIL. IN 1983; CAPOTEN SALES NEARLY DOUBLE TO ABOUT $95 MIL.; BIG OPERATING PROFIT GAINS BY DRUGS

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet